Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $10.90M.
ENTERPRISE VALUE (EV)
$10.90M
Citius Pharmaceuticals, Inc.
Market Cap
$14.15M
Enterprise Value (EV)
$10.90M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | $14.15M | $10.90M |
| Vyome Holdings, Inc. (HIND)vs › | $13.83M | $5.96M |
| IN8bio, Inc. (INAB)vs › | $13.71M | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.37M | $11.25M |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.53M | N/A |
| Optimi Health Corp. (OPTH)vs › | $13.44M | $7.87M |
| Passage Bio, Inc. (PASG)vs › | $13.30M | N/A |
| Cytosorbents Corporation (CTSO)vs › | $13.07M | $34.99M |
| Cellectar Biosciences, Inc. (CLRB)vs › | $13.02M | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.10M | $176.01M |
Market Cap
$14.15M
Total Debt
$1.00M
Cash
$4.25M
Enterprise Value
$10.90M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
